These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19680131)

  • 1. The acute effects of HIV protease inhibitors on insulin suppression of glucose production in healthy HIV-negative men.
    Lee GA; Schwarz JM; Patzek S; Kim S; Dyachenko A; Wen M; Mulligan K; Schambelan M; Grunfeld C
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):246-8. PubMed ID: 19680131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers.
    Lee GA; Rao M; Mulligan K; Lo JC; Aweeka F; Schwarz JM; Schambelan M; Grunfeld C
    AIDS; 2007 Oct; 21(16):2183-90. PubMed ID: 18090045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal.
    Yan Q; Hruz PW
    J Acquir Immune Defic Syndr; 2005 Dec; 40(4):398-403. PubMed ID: 16280693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.
    Schütt M; Zhou J; Meier M; Klein HH
    J Endocrinol; 2004 Dec; 183(3):445-54. PubMed ID: 15590971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration in pancreatic islet function in human immunodeficiency virus.
    Haugaard SB
    Endocrinol Metab Clin North Am; 2014 Sep; 43(3):697-708. PubMed ID: 25169562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers.
    Taylor SA; Lee GA; Pao VY; Anthonypillai J; Aweeka FT; Schwarz JM; Mulligan K; Schambelan M; Grunfeld C
    J Acquir Immune Defic Syndr; 2010 Nov; 55(3):361-4. PubMed ID: 20595906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
    Marzolini C; Telenti A; Buclin T; Biollaz J; Decosterd LA
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):43-58. PubMed ID: 10798293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects.
    Dubé MP; Gorski JC; Shen C
    Cardiovasc Toxicol; 2008 Mar; 8(1):15-22. PubMed ID: 18172783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study.
    Noor MA; Seneviratne T; Aweeka FT; Lo JC; Schwarz JM; Mulligan K; Schambelan M; Grunfeld C
    AIDS; 2002 Mar; 16(5):F1-8. PubMed ID: 11964551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indinavir increases glucose production in healthy HIV-negative men.
    Schwarz JM; Lee GA; Park S; Noor MA; Lee J; Wen M; Lo JC; Mulligan K; Schambelan M; Grunfeld C
    AIDS; 2004 Sep; 18(13):1852-4. PubMed ID: 15316349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy.
    Young EM; Considine RV; Sattler FR; Deeg MA; Buchanan TA; Degawa-Yamauchi M; Shankar S; Edmondson-Melançon H; Hernandez J; Dubé MP
    Cardiovasc Toxicol; 2004; 4(2):179-86. PubMed ID: 15371633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy.
    Eke AC; Wang J; Amin K; Shapiro DE; Stek A; Smith E; Chakhtoura N; Basar M; George K; Knapp KM; João EC; Rungruengthanakit K; Capparelli E; Burchett S; Mirochnick M; Best BM;
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amprenavir or fosamprenavir plus ritonavir in HIV infection: pharmacology, efficacy and tolerability profile.
    Arvieux C; Tribut O
    Drugs; 2005; 65(5):633-59. PubMed ID: 15748098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV protease inhibitors acutely impair glucose-stimulated insulin release.
    Koster JC; Remedi MS; Qiu H; Nichols CG; Hruz PW
    Diabetes; 2003 Jul; 52(7):1695-1700. PubMed ID: 12829635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro and in-vivo pharmacokinetic interactions of amprenavir, an HIV protease inhibitor, with other current HIV protease inhibitors in rats.
    Shibata N; Gao W; Okamoto H; Kishida T; Yoshikawa Y; Takada K
    J Pharm Pharmacol; 2002 Feb; 54(2):221-9. PubMed ID: 11848286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interactions. Amprenavir with low-dose ritonavir.
    TreatmentUpdate; 2006; 18(3):9-10. PubMed ID: 17211921
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV.
    Collier AC; Tierney C; Downey GF; Eshleman SH; Kashuba A; Klingman K; Vergis EN; Pakes GE; Rooney JF; Rinehart A; Mellors JW;
    HIV Clin Trials; 2008; 9(2):91-102. PubMed ID: 18474494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of indinavir in healthy HIV-seronegative men.
    Noor MA; Lo JC; Mulligan K; Schwarz JM; Halvorsen RA; Schambelan M; Grunfeld C
    AIDS; 2001 May; 15(7):F11-8. PubMed ID: 11399973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of various HIV protease inhibitors on function of rat insulinoma cells].
    Zhou JQ; Li WP; Xiang Z; Schutt M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 May; 35(3):251-4. PubMed ID: 16764025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of HIV protease inhibitors on carbohydrate and lipid metabolism.
    Lee GA; Rao MN; Grunfeld C
    Curr HIV/AIDS Rep; 2005 Feb; 2(1):39-50. PubMed ID: 16091248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.